Development of nonhuman adenoviruses as vaccine vectors.
Development of nonhuman adenoviruses as vaccine vectors.
复制标题
DOI:
10.1016/j.vaccine.2005.08.101
复制
发表时间:
2006-02-13
期刊:
影响因子:
5.5
通讯作者:
Mittal, SK
中科院分区:
文献类型:
--
作者:
Bangari, DS;Mittal, SK
关键词:
Human adenoviral (HAd) vectors have demonstrated great potential as vaccine vectors. Preclinical and clinical studies have demonstrated the feasibility of vector design, robust antigen expression and protective immunity using this system. However, clinical use of adenoviral vectors for vaccine purposes is anticipated to be limited by vector immunity that is either preexisting or develops rapidly following the first inoculation with adenoviral vectors. Vector immunity inactivates the vector particles and rapidly removes the transduced cells, thereby limiting the duration of transgene expression. Due to strong vector immunity, subsequent use of the same vector is usually less efficient. In order to circumvent this limitation, nonhuman adenoviral vectors have been proposed as alternative vectors. In addition to eluding HAd immunity, these vectors possess most of the attractive features of HAd vectors. Several replication-competent or replication-defective nonhuman adenoviral vectors have been developed and investigated for their potential as vaccine-delivery vectors. Here, we review recent advances in the design and characterization of various nonhuman adenoviral vectors, and discuss their potential applications for human and animal vaccination.
登录
查看更多内容
影响因子:
5.4
作者:
Chiocca, S;Baker, A;Cotten, M
通讯作者:
Cotten, M
影响因子:
4
作者:
Both, GW
通讯作者:
Both, GW
影响因子:
5.4
作者:
Casimiro, DR;Tang, AM;Shiver, JW
通讯作者:
Shiver, JW
影响因子:
3.7
作者:
Bangari, DS;Mittal, SK
通讯作者:
Mittal, SK
DOI:
10.1016/j.bbrc.2004.12.099
发表时间:
2005-02-18
影响因子:
3.1
作者:
Bangari, DS;Shukla, S;Mittal, SK
通讯作者:
Mittal, SK